| |
| |
|
| Insider
Information: |
Crocker Gary L |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
133,105 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$2,013,879 |
|
|
| Total
Shares |
133,105 |
|
|
| Total
Value |
$2,013,879 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
44
|
2
|
|
Stock
price went up :
|
19
|
2
|
| Stock
price went down : |
25
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
 24.3%
|
204.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merrimack Pharmaceuticals Inc |
MACK |
|
2020-07-22 |
0 |
2023-08-11 |
133,105 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2022-04-21 |
4 |
B |
$6.00 |
$30,001 |
I/I |
5,000 |
115,338 |
2.66 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2022-05-12 |
4 |
B |
$5.04 |
$12,456 |
I/I |
2,471 |
117,809 |
2.58 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2022-05-13 |
4 |
B |
$4.90 |
$15 |
I/I |
3 |
117,812 |
2.58 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2022-05-17 |
4 |
B |
$5.10 |
$1,147 |
I/I |
225 |
118,037 |
2.58 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2022-05-18 |
4 |
B |
$5.08 |
$25,407 |
I/I |
5,000 |
123,037 |
2.66 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2022-05-19 |
4 |
B |
$5.04 |
$2,582 |
I/I |
512 |
123,549 |
2.58 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2022-05-24 |
4 |
B |
$5.09 |
$11,817 |
I/I |
2,323 |
125,872 |
2.58 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2022-05-25 |
4 |
B |
$5.13 |
$678 |
I/I |
132 |
126,004 |
2.58 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2022-06-09 |
4 |
B |
$5.15 |
$22,918 |
I/I |
4,452 |
131,105 |
2.58 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2023-08-10 |
4 |
B |
$12.52 |
$25,039 |
I/I |
2,000 |
133,105 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2023-08-11 |
4 |
B |
$12.43 |
$24,865 |
I/I |
2,000 |
133,105 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2012-12-19 |
5 |
GA |
$0.00 |
$0 |
I/I |
69,030 |
2,471,271 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2012-12-19 |
5 |
GD |
$0.00 |
$0 |
I/I |
129,090 |
2,441,241 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2014-03-12 |
4 |
OE |
$1.25 |
$62,500 |
D/D |
50,000 |
2,728,271 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2014-05-05 |
4 |
OE |
$1.25 |
$43,750 |
D/D |
35,000 |
2,773,271 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
Director |
– • – |
2015-04-02 |
4 |
OE |
$1.71 |
$183,350 |
D/D |
85,000 |
2,943,961 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2020-07-22 |
4 |
S |
$3.04 |
$362,903 |
D/D |
(117,963) |
0 |
0 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
• • – |
2020-07-22 |
4 |
S |
$3.04 |
$233,562 |
I/I |
(75,546) |
0 |
0 |
% |
|
68 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
